Structural stability and enzymatic activity of the SARS coronavirus main protease 3CLpro

被引：0
|
作者：
Barrila, JA [1 ]
Bacha, UM [1 ]
Freire, E [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
来源：
PROTEIN SCIENCE | 2004年 / 13卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
101
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [11] Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
    Anand, K
    Ziebuhr, J
    Wadhwani, P
    Mesters, JR
    Hilgenfeld, R
    SCIENCE, 2003, 300 (5626) : 1763 - 1767
  • [12] Kinetic and Crystallographic Analyses of SARS Coronavirus 3CLpro Inhibitors
    Ratia, Kiira
    Santarsiero, Bernard
    Xi, Kai
    Jukneliene, Dalia
    Harcourt, Brian
    Baker, Susan
    Ghosh, Arun
    Mesecar, Andrew
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2005, 61 : C236 - C236
  • [13] SARS-CoV-2 3CLpro (main protease) regulates caspase activation of gasdermin-D/E pores leading to secretion and extracellular activity of 3CLpro
    Grin, Peter M.
    Baid, Kaushal
    de Jesus, Hugo C. R.
    Kozarac, Nedim
    Bell, Peter A.
    Jiang, Steven Z.
    Kappelhoff, Reinhild
    Butler, Georgina S.
    Leborgne, Nathan G. F.
    Pan, Christina
    Pablos, Isabel
    Machado, Yoan
    Vederas, John C.
    Kim, Hugh
    Benarafa, Charaf
    Banerjee, Arinjay
    Overall, Christopher M.
    CELL REPORTS, 2024, 43 (12):
  • [14] Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus
    Hartini, Yustina
    Saputra, Bakti
    Wahono, Bryan
    Auw, Zerlinda
    Indayani, Friska
    Adelya, Lintang
    Namba, Gabriel
    Hariono, Maywan
    RESULTS IN CHEMISTRY, 2021, 3
  • [15] Key dimer interface residues impact the catalytic activity of 3CLpro, the main protease of SARS-CoV-2
    Ferreira, Juliana C.
    Fadl, Samar
    Rabeh, Wael M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (06)
  • [16] Development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3CLpro
    Bacha, Usman
    Barrila, Jennifer
    Gabelli, Sandra B.
    Kiso, Yoshiaki
    Amzel, L. Mario
    Freire, Ernesto
    CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 72 (01) : 34 - 49
  • [17] Sensitive detection of SARS-CoV-2 main protease 3CLpro with an engineered ribonuclease zymogen
    Wralstad, Evans C.
    Raines, Ronald T.
    PROTEIN SCIENCE, 2024, 33 (04)
  • [18] The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper
    Belenkaya, Svetlana V.
    Merkuleva, Iuliia A.
    Yarovaya, Olga I.
    Chirkova, Varvara Yu.
    Sharlaeva, Elena A.
    Shanshin, Daniil V.
    Volosnikova, Ekaterina A.
    Vatsadze, Sergey Z.
    Khvostov, Mikhail V.
    Salakhutdinov, Nariman F.
    Shcherbakov, Dmitriy N.
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2023, 11
  • [19] Bayesian Inference Elucidates the Catalytic Competency of the SARS-CoV-2 Main Protease 3CLpro
    Wralstad, Evans C.
    Sayers, Jessica
    Raines, Ronald T.
    ANALYTICAL CHEMISTRY, 2023, 95 (40) : 14981 - 14989
  • [20] A Study of Drug Repurposing to Identify SARS-CoV-2 Main Protease (3CLpro) Inhibitors
    Jo, Seri
    Signorile, Luca
    Kim, Suwon
    Kim, Mi-Sun
    Huertas, Oscar
    Insa, Raul
    Reig, Nuria
    Shin, Dong Hae
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (12)
12345